HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.

Abstract
Identification of a novel therapy for prevention of sudden death by ischemic cardiac infarction is an area of intensive investigation. We here report that the mortality due to an experimental acute myocardial infarction (AMI) was markedly increased in mice deficient in alpha2-antiplasmin (alpha2-AP(-/-) mice) but not in mice deficient in other components acting in fibrinolysis (tissue-type PA, urokinase type PA, or plasminogen activator inhibitor-1) even if the infarct area in alpha2-AP(-/-) mice was not different from those in the other mice. Echocardiography showed in alpha2-AP(-/-) mice after AMI an overload of the right ventricle and that pulmonary permeability was increased. According to the experiments using explanted myocytes and vascular smooth muscle cells, it was found that the amount of secreted vascular endothelial cell growth factor (VEGF) in alpha2-AP(-/-) mice was markedly increased compared with that in wild-type mice. Finally, an injection of an anti-VEGF antibody decreased the mortality after AMI in alpha2-AP(-/-) mice. Plasmin cleaves extracellular matrix-bound VEGF to release a diffusible proteolytic fragment and is inactivated mainly by alpha2-AP. Therefore, lack of alpha2-AP could markedly result in overrelease of VEGF by the continuous activation of plasmin because of AMI and could result in an acute cor pulmonale. Our results provide new aspects on the role of alpha2-AP and VEGF in the pathogenesis of cardiac events.
AuthorsHiroyuki Matsuno, Osamu Kozawa, Naoki Yoshimi, Shigeru Akamatsu, Akira Hara, Hideki Mori, Kiyotaka Okada, Shigeru Ueshima, Osamu Matsuo, Toshihiko Uematsu
JournalBlood (Blood) Vol. 100 Issue 7 Pg. 2487-93 (Oct 01 2002) ISSN: 0006-4971 [Print] United States
PMID12239160 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • alpha-2-Antiplasmin
Topics
  • Animals
  • Echocardiography
  • Endothelial Growth Factors (blood, genetics, metabolism)
  • Intercellular Signaling Peptides and Proteins (blood, genetics, metabolism)
  • Lung (pathology)
  • Lymphokines (blood, genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Myocardial Infarction (diagnostic imaging, pathology, physiopathology)
  • Pulmonary Heart Disease (genetics, pathology, physiopathology)
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • alpha-2-Antiplasmin (deficiency, genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: